Recent Advances in Studies on Hydroxamates as Matrix Metalloproteinase Inhibitors: A Review

E-ISSN： 1875-533x|18|11|1704-1722

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.11, 2011-04, pp. : 1704-1722

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sulfone reverse hydroxamates as matrix metalloproteinase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. : 133-143

Informa Healthcare

Access to resources Recommend Favorite

Recent non-hydroxamate matrix metalloproteinase inhibitors

By Breuer Eli Frant Julia Reich Reuven

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 3, 2005-03 ,pp. : 253-269

Informa Healthcare

Access to resources Recommend Favorite

Advances in Matrix Metalloproteinase Inhibitors Based on Pyrrolidine Scaffold

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 374-385

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in the Design of Specific Matrix Metalloproteinase Inhibitors aided by Structural and Computational Studies

Current Pharmaceutical Design, Vol. 11, Iss. 3, 2005-02 ,pp. : 295-322

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1213-1216

Informa Healthcare

Access to resources Recommend Favorite